GLSI
Price
$11.77
Change
-$0.33 (-2.73%)
Updated
Mar 10, 04:47 PM (EDT)
Capitalization
159.05M
69 days until earnings call
SAGE
Price
$7.28
Change
-$0.22 (-2.93%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
461.11M
56 days until earnings call
Ad is loading...

GLSI vs SAGE

Header iconGLSI vs SAGE Comparison
Open Charts GLSI vs SAGEBanner chart's image
Greenwich LifeSciences
Price$11.77
Change-$0.33 (-2.73%)
Volume$400
Capitalization159.05M
Sage Therapeutics
Price$7.28
Change-$0.22 (-2.93%)
Volume$50.14K
Capitalization461.11M
GLSI vs SAGE Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. SAGE commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and SAGE is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (GLSI: $12.10 vs. SAGE: $7.50)
Brand notoriety: GLSI and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 74% vs. SAGE: 49%
Market capitalization -- GLSI: $159.05M vs. SAGE: $461.11M
GLSI [@Biotechnology] is valued at $159.05M. SAGE’s [@Biotechnology] market capitalization is $461.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, SAGE is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 5 TA indicator(s) are bullish while SAGE’s TA Score has 3 bullish TA indicator(s).

  • GLSI’s TA Score: 5 bullish, 2 bearish.
  • SAGE’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than SAGE.

Price Growth

GLSI (@Biotechnology) experienced а -0.98% price change this week, while SAGE (@Biotechnology) price change was +2.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

GLSI is expected to report earnings on May 19, 2025.

SAGE is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($461M) has a higher market cap than GLSI($159M). SAGE YTD gains are higher at: 38.122 vs. GLSI (7.747). GLSI has higher annual earnings (EBITDA): -10.76M vs. SAGE (-371.15M). SAGE has more cash in the bank: 569M vs. GLSI (5.82M). SAGE has higher revenues than GLSI: SAGE (106M) vs GLSI (0).
GLSISAGEGLSI / SAGE
Capitalization159M461M34%
EBITDA-10.76M-371.15M3%
Gain YTD7.74738.12220%
P/E RatioN/AN/A-
Revenue0106M-
Total Cash5.82M569M1%
Total DebtN/A10.3M-
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSISAGE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 13 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEYX12.690.11
+0.87%
Saratoga International Equity A
SILLX25.040.19
+0.76%
Franklin Global Equity C
AMIDX13.080.09
+0.69%
Amana Developing World Institutional
JDVIX14.730.09
+0.61%
JHancock Disciplined Value Intl I
FGFAX40.220.04
+0.10%
Federated Hermes International Leaders A

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with DNLI. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+1.68%
DNLI - GLSI
35%
Loosely correlated
+2.58%
ORMP - GLSI
35%
Loosely correlated
+9.36%
ABOS - GLSI
33%
Poorly correlated
+0.81%
ATOS - GLSI
32%
Poorly correlated
-1.72%
FHTX - GLSI
32%
Poorly correlated
+0.44%
More

SAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SAGE has been loosely correlated with AXON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAGE
1D Price
Change %
SAGE100%
-1.06%
AXON - SAGE
42%
Loosely correlated
+5.43%
HRMY - SAGE
39%
Loosely correlated
-0.12%
KZR - SAGE
36%
Loosely correlated
+0.33%
THRD - SAGE
34%
Loosely correlated
-2.51%
CGEN - SAGE
34%
Loosely correlated
-0.60%
More